N-Boc-2-methyl-D-serine is a chiral, non-natural amino acid derivative featuring a tert-butoxycarbonyl (Boc) protecting group on the amino moiety and a methyl substituent at the alpha-carbon position. This compound belongs to the class of alpha-methyl amino acids, which are known for inducing conformational constraints in peptides. Its molecular structure combines a hindered serine backbone with a D-configuration, making it a valuable building block for stereochemically defined synthesis. This product is primarily utilized as a key intermediate in the synthesis of complex pharmaceuticals, particularly in the development of peptide-based drugs and enzyme inhibitors. The Boc group allows for orthogonal deprotection under acidic conditions, while the D-serine scaffold imparts metabolic stability and enhanced binding selectivity to therapeutic candidates. It is also employed in medicinal chemistry for structure-activity relationship (SAR) studies targeting neurological and metabolic disorders. As a protected derivative of a rare amino acid, it serves as a standard reagent in solid-phase peptide synthesis (SPPS) and combinatorial chemistry. Its high enantiomeric purity and defined stereochemistry are critical for producing chiral pharmaceuticals and bioactive molecules. The compound is typically stored under inert atmosphere to prevent degradation.